Pharma-Biotech Companies

Pharma-Biotech Companies overview

PGDx offers a suite of cancer genome analyses services to identify alterations in any tumor of interest. Our services sensitively and specifically identify genomic variants which can be linked to the underlying biology of cancer.

Sample types Tissue Tissue Liquidbiopsy Liquidbiopsy
Analysis
Characteristics
CancerXOME™ CancerSELECT™ 125 PlasmaSELECT™ R MetDETECT™
Regions Analyzed >20,000 Genes 125 Genes 64 Genes MET Region
Sample Prep &
NGS Sequencing
Sequence Mapping
Somatic Mutation
Analysis
N/A
Copy Number
Analysis
Structural Alteration
Analysis
N/A
Germline Variant
Analysis
N/A N/A
Pathway &
Functional Analysis
N/A N/A
Integrated Project
Analysis
CancerXOME™
Sample Type   Tissue
Regions Analyzed   >20,000 Genes
Sample Prep &
NGS Sequencing
 
Sequence Mapping  
Somatic Mutation Analysis  
Copy Number Analysis  
Structural Alteration Analysis   N/A
Germline Variant Analysis  
Pathway & Functional Analysis  
Integrated Project Analysis  
CancerSELECT™ 125
Sample Type   Tissue
Regions Analyzed   125 Genes
Sample Prep &
NGS Sequencing
 
Sequence Mapping  
Somatic Mutation Analysis  
Copy Number Analysis  
Structural Alteration Analysis  
Germline Variant Analysis  
Pathway & Functional Analysis  
Integrated Project Analysis  
PlasmaSELECT™ R
Sample Type   Liquid Biopsy
Regions Analyzed   64 Genes
Sample Prep &
NGS Sequencing
 
Sequence Mapping  
Somatic Mutation Analysis  
Copy Number Analysis  
Structural Alteration Analysis  
Germline Variant Analysis   N/A
Pathway & Functional Analysis   N/A
Integrated Project Analysis  
MetDETECT™
Sample Type   Liquid Biopsy
Regions Analyzed   MET Region
Sample Prep &
NGS Sequencing
 
Sequence Mapping  
Somatic Mutation Analysis   N/A
Copy Number Analysis  
Structural Alteration Analysis  
Germline Variant Analysis   N/A
Pathway & Functional Analysis   N/A
Integrated Project Analysis  

* Germline variant analysis is optional forthese approaches when matched normal is provided